home / stock / rcar / rcar news

RCAR News and Press, Renovacare Inc From 06/10/20

Stock Information
Company Name: Renovacare Inc
Stock Symbol: RCAR
Market: OTC
Website: renovacareinc.com
Menu
RCAR RCAR Quote RCAR Short RCAR News RCAR Articles RCAR Message Board
Get RCAR Alerts

News, Short Squeeze, Breakout and More Instantly...
RCAR - RenovaCare Appoints Chief Medical Officer, Dr. Jo Ellen Schweinle, Former Sr. Medical Officer at U.S. Dept. of Health and Human Services

ROSELAND, N.J., June 10, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced the appointment of its first Chief...
RCAR - RenovaCare Strengthens FDA Program with Leading U.S. Regulatory Group and Significant Investment

ROSELAND, N.J., May 28, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that it has expanded its engagement...

RCAR - RenovaCare Appoints Founding Director of BARDA Dr. Robin A. Robinson to Chief Scientific Officer

ROSELAND, N.J., May 26, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that its Vice President, Scientific...

RCAR - RenovaCare's SkinGun used in RDEB gene therapy study

RenovaCare ( OTCPK:RCAR +0.8% ) announces that its SkinGun , a patented device for spraying self-donated stem cells for the regeneration of skin and other organs/tissues, is being used in a preclinical study at King's College London to apply gene-supplemented cells (gene therapy) for ac...
RCAR - Spray-On Gene Therapy With RenovaCare SkinGun(TM) in New Study Underway at King's College London

ROSELAND, N.J., March 30, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR;  www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that the Company’s no...

RCAR - RenovaCare Announces New Corporate Headquarters and Laboratory Facilities

ROSELAND, N.J., March 11, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR;  www.renovacareinc.com ), today announced new corporate headquarters in Roseland, New Jersey and laboratory facilities in Berlin, Germany to advance the development of its patented technologies for spr...

RCAR - RenovaCare Stockholder Update and 2020 Outlook from the CEO

SCOTTSDALE, Ariz., Dec. 05, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, is pleased to provide this update from its new CEO, Mr. Alan L. Rubino, as...
RCAR - Dr. Emanual Maverakis, Recipient of Presidential Award for Scientists and Engineers, Joins RenovaCare

SCOTTSDALE, Ariz., Nov. 26, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR;  www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, is pleased to announce the appointment of Dr. Emanual Mav...

RCAR - RenovaCare Appoints Alan L. Rubino as President and CEO

SCOTTSDALE, Ariz., Nov. 18, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR;  www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, today announced the appointment of  Alan L. Rubino a...

RCAR - Dr. Frank Gerberick, Procter & Gamble Product Safety Veteran, Joins RenovaCare

SCOTTSDALE, Ariz., Sept. 24, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR;  www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, is pleased to announce the appointment of Dr. Frank Gerb...
Previous 10 Next 10